Evidence map›Paper›PMID 28176036›Full record

ArticleClinical rheumatology2017

Association of serum uric acid and risk of hypertension in adults: a prospective study of Kailuan Corporation cohort.

Liu-Fu Cui, Hui-Jing Shi, Shou-Ling Wu, Rong Shu, Na Liu, Guan-Ying Wang, Bin Zhou, Kai Sun, Ping Yu, Jian Wang and 5 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Liu-Fu CuiDepartment of Rheumatology and Immunology, Hebei United University Kailuan Hospital, Tangshan, 063000, China.
Hui-Jing ShiDepartment of Rheumatology and Immunology, Hebei United University Kailuan Hospital, Tangshan, 063000, China.
Shou-Ling WuDepartment of Cardiology, Hebei United University Kailuan Hospital, Tangshan, 063000, China.
Rong ShuDepartment of Rheumatology and Immunology, Hebei United University Kailuan Hospital, Tangshan, 063000, China.
Na LiuDepartment of Rheumatology and Immunology, Peking University People's Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing, 100044, China.
Guan-Ying WangDepartment of Rheumatology and Immunology, Peking University People's Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing, 100044, China.
Bin ZhouDepartment of Epidemiology & Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, 100191, China.
Kai SunDepartment of Rheumatology, Hospital for Special Surgery, New York, NY, 10021, USA.
Ping YuDepartment of Rheumatology and Immunology, Hebei United University Kailuan Hospital, Tangshan, 063000, China.
Jian WangDepartment of Rheumatology and Immunology, Hebei United University Kailuan Hospital, Tangshan, 063000, China.
Hai-Cheng SongDepartment of Rheumatology and Immunology, Hebei United University Kailuan Hospital, Tangshan, 063000, China.
Wen-Hao YangDepartment of Rheumatology and Immunology, Hebei United University Kailuan Hospital, Tangshan, 063000, China.
Jie-Rui WangDepartment of Rheumatology and Immunology, Hebei United University Kailuan Hospital, Tangshan, 063000, China.
Yi-Xuan HanDepartment of Rheumatology and Immunology, Hebei United University Kailuan Hospital, Tangshan, 063000, China.
Rong MuDepartment of Rheumatology and Immunology, Peking University People's Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing, 100044, China. murong@pkuph.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Whether hyperuricemia is an independent risk factor for hypertension in adults is still under debate. To determine the association between serum uric acid and risk of hypertension in the Chinese population, we conducted a prospective study using the "Kailuan Corporation cohort." A total of 39,233 adult subjects with available data on serum uric acid were enrolled from 2006 to 2007. Subjects with established hypertension were excluded and were then grouped based on the gender and baseline quartile serum uric acid into F1-4 for women and M1-4 for men with F1 and M1 being the lowest quartiles. Incidence of newly described primary hypertension was reevaluated in 2010-2011. The median (interquantile range) baseline uric acid (UA) was 290 (243-344) μmol/L in men and 230 (194-274) μmol/L in women. During a 4-year follow-up period, 12,844 subjects (31.31 %) were newly diagnosed with hypertension. The incidence of hypertension was 14.36, 16.57, 19.06, and 22.35 % in F1 to F4 and 33.64, 33.97, 36.54, and 40.74 % in M1 to M4, respectively. Multiple logistic regression analysis showed that the odds ratios (ORs) of incident hypertension were 1.17 [95 % confidence interval (CI) 1.00-1.37, P = 0.055], 1.24 (95 % CI 1.06-1.45, P = 0.009), and 1.20 (95 % CI 1.02-1.41, P = 0.027) in F2 to F4 compared to the F1 and 0.98 (95 % CI 0.91-1.05, P = 0.534), 1.05 (95 % CI 0.98-1.13, P = 0.190), and 1.13 (95 % CI 1.05-1.22, P = 0.002) in M2 to M4 compared to the M1. Elevated level of serum uric acid is associated with an increased risk of hypertension in adults.

Indexed as

Blood PressureAdolescentAdultAgedAged, 80 and overBiomarkersChinaFemaleFollow-Up StudiesHumansHypertensionHyperuricemiaIncidenceMaleMiddle AgedOdds RatioBiomarkersUric AcidCohort studyHypertensionProspective studySerum uric acid

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.